Atrys Health SA
MAD:ATRY
Relative Value
The Relative Value of one ATRY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.92 EUR, Atrys Health SA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ATRY Competitors Multiples
Atrys Health SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
A
|
Atrys Health SA
MAD:ATRY
|
220m EUR | 1 | -9 | 8.9 | 66.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD | 0.3 | 212.6 | 14 | 14 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.2B USD | 0.3 | 12.7 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR | 0.3 | 12.2 | 7.8 | 9.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR | 1.2 | 24.3 | 10.6 | 16.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR | 1.2 | 33.1 | 10.4 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD | 1.7 | 26.9 | 14.4 | 20.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD | 2 | 22.4 | 12.2 | 16.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 16.2 | 6.4 | 13.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD | 14.1 | -31.8 | -33.6 | -30.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 12.9 | 7.3 | 10 |